| Year |
Citation |
Score |
| 2022 |
Verrier ER, Ligat G, Heydmann L, Doernbrack K, Miller J, Maglott-Roth A, Jühling F, El Saghire H, Heuschkel MJ, Fujiwara N, Hsieh SY, Hoshida Y, Root DE, Felli E, Pessaux P, ... ... Mailly L, et al. Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target. Gut. PMID 36591611 DOI: 10.1136/gutjnl-2020-323665 |
0.304 |
|
| 2021 |
Zhuang X, Tsukuda S, Wrensch F, Wing PA, Schilling M, Harris JM, Borrmann H, Morgan SB, Cane JL, Mailly L, Thakur N, Conceicao C, Sanghani H, Heydmann L, Bach C, et al. The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells. Iscience. 103144. PMID 34545347 DOI: 10.1016/j.isci.2021.103144 |
0.357 |
|
| 2021 |
Zhuang X, Tsukuda S, Wrensch F, Wing PA, Borrmann H, Harris JM, Morgan SB, Mailly L, Thakur N, Conceicao C, Sanghani H, Heydmann L, Bach C, Ashton A, Walsh S, et al. Circadian regulation of SARS-CoV-2 infection in lung epithelial cells. Biorxiv : the Preprint Server For Biology. PMID 33758862 DOI: 10.1101/2021.03.20.436163 |
0.322 |
|
| 2020 |
Mailly L, Baumert TF. Hepatitis C virus infection and tight junction proteins: The ties that bind. Biochimica Et Biophysica Acta. Biomembranes. 1862: 183296. PMID 32268133 DOI: 10.1016/J.Bbamem.2020.183296 |
0.405 |
|
| 2019 |
Aizarani N, Saviano A, Sagar, Mailly L, Durand S, Herman JS, Pessaux P, Baumert TF, Grün D. A human liver cell atlas reveals heterogeneity and epithelial progenitors. Nature. PMID 31292543 DOI: 10.1038/S41586-019-1373-2 |
0.355 |
|
| 2018 |
Mailly L, Wrensch F, Heydmann L, Fauvelle C, Brignon N, Zeisel MB, Pessaux P, Keck ZY, Schuster C, Fuerst TR, Foung SKH, Baumert TF. In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection. Antiviral Research. 162: 136-141. PMID 30599173 DOI: 10.1016/J.Antiviral.2018.12.018 |
0.392 |
|
| 2018 |
Verrier ER, Yim SA, Heydmann L, El Saghire H, Bach C, Turon-Lagot V, Mailly L, Durand SC, Lucifora J, Durantel D, Pessaux P, Manel N, Hirsch I, Zeisel MB, Pochet N, et al. Hepatitis B virus evasion from cGAS sensing in human hepatocytes. Hepatology (Baltimore, Md.). PMID 29679386 DOI: 10.1002/Hep.30054 |
0.454 |
|
| 2018 |
Douam F, Fusil F, Enguehard M, Dib L, Nadalin F, Schwaller L, Hrebikova G, Mancip J, Mailly L, Montserret R, Ding Q, Maisse C, Carlot E, Xu K, Verhoeyen E, et al. A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism. Plos Pathogens. 14: e1006908. PMID 29505618 DOI: 10.1371/Journal.Ppat.1006908 |
0.349 |
|
| 2018 |
Verrier E, Weiss A, Bach C, Heydmann L, Mailly L, Garcia T, Pale P, Schuster C, Sureau C, Zeisel M, Brino L, Baumert T. Estrogen receptor R1 and CAD are host factors for HDV replication and antiviral targets Journal of Hepatology. 68. DOI: 10.1016/S0168-8278(18)31846-4 |
0.311 |
|
| 2017 |
Lucifora J, Salvetti A, Marniquet X, Mailly L, Testoni B, Fusil F, Inchauspé A, Michelet M, Michel ML, Levrero M, Cortez P, Baumert TF, Cosset FL, Challier C, Zoulim F, et al. Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector. Antiviral Research. PMID 28709657 DOI: 10.1016/J.Antiviral.2017.07.006 |
0.357 |
|
| 2017 |
Mailly L, Zeisel MB, Baumert TF. Towards novel immunocompetent animal models for hepatitis B virus infection. Hepatology (Baltimore, Md.). PMID 28470681 DOI: 10.1002/Hep.29249 |
0.391 |
|
| 2017 |
Colpitts CC, Tawar RG, Mailly L, Thumann C, Heydmann L, Durand SC, Xiao F, Robinet E, Pessaux P, Zeisel MB, Baumert TF. Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape. Gut. PMID 28360099 DOI: 10.1136/Gutjnl-2016-312577 |
0.358 |
|
| 2017 |
Farquhar MJ, Humphreys IS, Rudge SA, Wilson GK, Bhattacharya B, Ciaccia M, Hu K, Zhang Q, Mailly L, Reynolds GM, Aschcroft M, Balfe P, Baumert TF, Roessler S, Wakelam MJ, et al. Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication. Journal of Hepatology. PMID 28126468 DOI: 10.1016/J.Jhep.2017.01.009 |
0.334 |
|
| 2016 |
Tawar RG, Colpitis CC, Mailly L, Thumann C, Xiao F, Heydmann L, Durand SC, Pessaux P, Zeisel MB, Baumert TF. Humanization of Atherapeutic Claudin-1-Specific Antibody to Cure Hepatitis C Virus Infection in Monotherapy Journal of Hepatology. 64. DOI: 10.1016/S0168-8278(16)01702-5 |
0.379 |
|
| 2015 |
Bonetta AC, Mailly L, Robinet E, Travé G, Masson M, Deryckere F. Artificial microRNAs against the viral E6 protein provoke apoptosis in HPV positive cancer cells. Biochemical and Biophysical Research Communications. 465: 658-64. PMID 26241675 DOI: 10.1016/J.Bbrc.2015.07.144 |
0.309 |
|
| 2015 |
Mailly L, Xiao F, Lupberger J, Wilson GK, Aubert P, Duong FH, Calabrese D, Leboeuf C, Fofana I, Thumann C, Bandiera S, Lütgehetmann M, Volz T, Davis C, Harris HJ, et al. Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody. Nature Biotechnology. 33: 549-54. PMID 25798937 DOI: 10.1038/Nbt.3179 |
0.425 |
|
| 2015 |
Xiao F, Fofana I, Thumann C, Mailly L, Alles R, Robinet E, Meyer N, Schaeffer M, Habersetzer F, Doffoël M, Leyssen P, Neyts J, Zeisel MB, Baumert TF. Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C. Gut. 64: 483-94. PMID 24848265 DOI: 10.1136/Gutjnl-2013-306155 |
0.405 |
|
| 2015 |
Mailly L, Xiao F, Lupberger J, Wilson GK, Aubert P, Duong FH, Calabrese D, Leboeuf C, Fofana I, Thumann C, Bandiera S, Lütgehetmann M, Volz T, Davis C, Harris HJ, et al. P0676 : Clearance of persistent hepatitis c virus infection using a monoclonal antibody specific for tight junction protein claudin-1 Journal of Hepatology. 62. DOI: 10.1016/S0168-8278(15)30880-1 |
0.36 |
|
| 2014 |
Tawar RG, Mailly L, Baumert TF. A new HCV mouse model on the block. Cell Research. 24: 1153-4. PMID 25257465 DOI: 10.1038/Cr.2014.126 |
0.33 |
|
| 2014 |
Leboeuf C, Mailly L, Wu T, Bour G, Durand S, Brignon N, Ferrand C, Borg C, Tiberghien P, Thimme R, Pessaux P, Marescaux J, Baumert TF, Robinet E. In vivo proof of concept of adoptive immunotherapy for hepatocellular carcinoma using allogeneic suicide gene-modified killer cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 634-44. PMID 24445938 DOI: 10.1038/Mt.2013.277 |
0.471 |
|
| 2014 |
Mailly L, Zeisel MB, Baumert TF. Genetically humanized mice recapitulate the entire hepatitis C virus life cycle. Journal of Hepatology. 60: 671-3. PMID 24128418 DOI: 10.1016/J.Jhep.2013.10.005 |
0.372 |
|
| 2014 |
Wilson GK, Meredith LW, Greenland D, Mailly L, Tennant D, Ashcroft M, Baumert TF, Tomlinson JW, Hubscher SG, Eeden FV, Balfe P, McKeating JA. P191 Hepatitis B And C Virus Promote Crosstalk Between Hypoxia And Glucocorticoid Signalling Pathways To Re-Programme Hepatocyte Metabolism And To Evade Host Interferons Journal of Hepatology. 60. DOI: 10.1016/S0168-8278(14)60353-6 |
0.332 |
|
| 2013 |
Mailly L, Robinet E, Meuleman P, Baumert TF, Zeisel MB. Hepatitis C virus infection and related liver disease: the quest for the best animal model. Frontiers in Microbiology. 4: 213. PMID 23898329 DOI: 10.3389/Fmicb.2013.00212 |
0.355 |
|
| 2012 |
El-Andaloussi N, Bonifati S, Kaufmann JK, Mailly L, Daeffler L, Deryckère F, Nettelbeck DM, Rommelaere J, Marchini A. Generation of an adenovirus-parvovirus chimera with enhanced oncolytic potential. Journal of Virology. 86: 10418-31. PMID 22787235 DOI: 10.1128/JVI.00848-12 |
0.314 |
|
| 2011 |
Leboeuf C, Mailly L, Baumert TF, Robinet E. 245 In Vivo Proof-Of-Concept Of Adoptive Immunotherapy For Hepatocellular Carcinoma With An Infusion Of Allogeneic Suicide Gene-Modified Killer Cells Journal of Hepatology. 54. DOI: 10.1016/S0168-8278(11)60247-X |
0.384 |
|
| 2010 |
Mailly L, Leboeuf C, Tiberghien P, Baumert T, Robinet E. Genetically engineered T-cells expressing a ganciclovir-sensitive HSV-tk suicide gene for the prevention of GvHD. Current Opinion in Investigational Drugs (London, England : 2000). 11: 559-70. PMID 20419602 |
0.447 |
|
| 2010 |
Leboeuf C, Mailly L, Ferrand C, Tiberghien P, Wolf P, Doffoel M, Baumert TF, Robinet E. 878 Allogeneic Adoptive Immunotherapy Of The Hepatocellular Carcinoma By Infusion Of “Ready-To-Use” Allogeneic Suicide Gene-Modified T Cells Journal of Hepatology. 52. DOI: 10.1016/S0168-8278(10)60879-3 |
0.378 |
|
| 2009 |
Mailly L, Leboeuf C, Ferrand C, Tiberghien P, Bour G, Aprahamian M, Doffoel M, Wolf P, Baumert T, Robinet E. Allogeneic Suicide Gene-Modified T Cells (aSGMTC) Are Highly Cytotoxic to Non-Hematopoietic Tumor Cell Lines: Rationale for the Production of a Bank of aSGMTC for the Treatment of Solid Tumors. Blood. 114: 2459-2459. DOI: 10.1182/Blood.V114.22.2459.2459 |
0.54 |
|
| 2008 |
Mailly L, Boulade-Ladame C, Orfanoudakis G, Deryckere F. A novel adenovirus vector for easy cloning in the E3 region downstream of the CMV promoter. Virology Journal. 5: 73. PMID 18538014 DOI: 10.1186/1743-422X-5-73 |
0.384 |
|
| 2006 |
Mailly L, Renaut L, Rogée S, Grellier E, D'Halluin JC, Colin M. Improved gene delivery to B lymphocytes using a modified adenovirus vector targeting CD21. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 293-304. PMID 16735140 DOI: 10.1016/J.Ymthe.2006.03.017 |
0.547 |
|
| 2005 |
Colin M, Mailly L, Rogée S, D'Halluin JC. Efficient species C HAdV infectivity in plasmocytic cell lines using a clathrin-independent lipid raft/caveola endocytic route. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 224-36. PMID 15668134 DOI: 10.1016/J.Ymthe.2004.10.007 |
0.692 |
|
| 2004 |
Colin M, Renaut L, Mailly L, D'Halluin JC. Factors involved in the sensitivity of different hematopoietic cell lines to infection by subgroup C adenovirus: implication for gene therapy of human lymphocytic malignancies. Virology. 320: 23-39. PMID 15003860 DOI: 10.1016/J.Virol.2003.09.043 |
0.668 |
|
| Show low-probability matches. |